A Trusted Data Source for Supply & Demand Side Intelligence

Forgot your login?

Enter the e-mail address you used when you registered an account with IIR Energy.

A message will be sent to the E-Mail Address found in our records containing the associated username(s) as well as instructions for a password reset.

E-Mail:
Also, what is 63 + 9?

Lonza Building New Swiss Plant, Expands Moderna COVID-19 Manufacturing Deal

Lonza Building New Swiss Plant, Expands Moderna COVID-19 Manufacturing Deal

GALWAY, IRELAND--May 5, 2021--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Swiss contract development and manufacturing organization (CDMO) Lonza Group (Basel, Switzerland) has announced a series of major projects for its Visp facility in Switzerland, including a new $218 million small molecule manufacturing complex and separate plans to double the drug substance production for Moderna's (NASDAQ:MRNA) (Cambridge, Massachusetts) COVID-19 vaccine.

Within this article: Details new small molecule plant investment, long-term COVID-19 deal with Moderna and related news

Login or Register for Instant Access

Subscribe Now!

(All Fields Required)